Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C12H19NO3 |
Molecular Weight | 225.2842 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)NC[C@H](O)COC1=CC=C(O)C=C1
InChI
InChIKey=ADUKCCWBEDSMEB-NSHDSACASA-N
InChI=1S/C12H19NO3/c1-9(2)13-7-11(15)8-16-12-5-3-10(14)4-6-12/h3-6,9,11,13-15H,7-8H2,1-2H3/t11-/m0/s1
Molecular Formula | C12H19NO3 |
Molecular Weight | 225.2842 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Noninvasive assessment of chronotropic and inotropic response to preferential beta-1 and beta-2 adrenoceptor stimulation. | 1984 Jun |
|
Beta 1- and beta 2-adrenergic receptor-mediated adenylate cyclase stimulation in nonfailing and failing human ventricular myocardium. | 1989 Mar |
|
alpha- and beta-adrenergic receptor mechanisms in spontaneous contractile activity of rat ileal longitudinal smooth muscle. | 2005 Feb |
|
Role of selective alpha and beta adrenergic receptor mechanisms in rat jejunal longitudinal muscle contractility. | 2008 Jun |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/7270401
The eight patients were given prenalterol (PNL) orally, 30 to 200 mg/day, versus placebo for 6 days
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:59:01 GMT 2023
by
admin
on
Fri Dec 15 17:59:01 GMT 2023
|
Record UNII |
M4G34404CX
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QC01CA13
Created by
admin on Fri Dec 15 17:59:01 GMT 2023 , Edited by admin on Fri Dec 15 17:59:01 GMT 2023
|
||
|
WHO-ATC |
C01CA13
Created by
admin on Fri Dec 15 17:59:01 GMT 2023 , Edited by admin on Fri Dec 15 17:59:01 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
4121
Created by
admin on Fri Dec 15 17:59:01 GMT 2023 , Edited by admin on Fri Dec 15 17:59:01 GMT 2023
|
PRIMARY | |||
|
D011294
Created by
admin on Fri Dec 15 17:59:01 GMT 2023 , Edited by admin on Fri Dec 15 17:59:01 GMT 2023
|
PRIMARY | |||
|
M4G34404CX
Created by
admin on Fri Dec 15 17:59:01 GMT 2023 , Edited by admin on Fri Dec 15 17:59:01 GMT 2023
|
PRIMARY | |||
|
100000081428
Created by
admin on Fri Dec 15 17:59:01 GMT 2023 , Edited by admin on Fri Dec 15 17:59:01 GMT 2023
|
PRIMARY | |||
|
42396
Created by
admin on Fri Dec 15 17:59:01 GMT 2023 , Edited by admin on Fri Dec 15 17:59:01 GMT 2023
|
PRIMARY | |||
|
DB13777
Created by
admin on Fri Dec 15 17:59:01 GMT 2023 , Edited by admin on Fri Dec 15 17:59:01 GMT 2023
|
PRIMARY | |||
|
C174691
Created by
admin on Fri Dec 15 17:59:01 GMT 2023 , Edited by admin on Fri Dec 15 17:59:01 GMT 2023
|
PRIMARY | |||
|
DTXSID8023507
Created by
admin on Fri Dec 15 17:59:01 GMT 2023 , Edited by admin on Fri Dec 15 17:59:01 GMT 2023
|
PRIMARY | |||
|
260-791-5
Created by
admin on Fri Dec 15 17:59:01 GMT 2023 , Edited by admin on Fri Dec 15 17:59:01 GMT 2023
|
PRIMARY | |||
|
Prenalterol
Created by
admin on Fri Dec 15 17:59:01 GMT 2023 , Edited by admin on Fri Dec 15 17:59:01 GMT 2023
|
PRIMARY | |||
|
SUB10027MIG
Created by
admin on Fri Dec 15 17:59:01 GMT 2023 , Edited by admin on Fri Dec 15 17:59:01 GMT 2023
|
PRIMARY | |||
|
57526-81-5
Created by
admin on Fri Dec 15 17:59:01 GMT 2023 , Edited by admin on Fri Dec 15 17:59:01 GMT 2023
|
PRIMARY | |||
|
2258
Created by
admin on Fri Dec 15 17:59:01 GMT 2023 , Edited by admin on Fri Dec 15 17:59:01 GMT 2023
|
PRIMARY | |||
|
CHEMBL1160714
Created by
admin on Fri Dec 15 17:59:01 GMT 2023 , Edited by admin on Fri Dec 15 17:59:01 GMT 2023
|
PRIMARY | |||
|
m9123
Created by
admin on Fri Dec 15 17:59:01 GMT 2023 , Edited by admin on Fri Dec 15 17:59:01 GMT 2023
|
PRIMARY | Merck Index |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |